HCA Healthcare, Inc.
NYSE:HCAMedical - Care Facilities
-$12.05 today
- Market cap
- $99.51B
- Beta
- 1.13
- P/E (TTM)
- 12.5
- EPS (TTM)
- $29.98
- Dividend yield
- 0.80%
Volume 1.60M
Average 1.37M
HCA Other Stockholders Equity
Equity items not reported separately, such as additional paid-in capital or treasury stock.
HCA Healthcare, Inc.NYSE: HCA
Other Stockholders Equity · Q2 FY2026 · quarter ended Jun 2026
Other stockholders equity remains negative
Q2 FY2026 other stockholders equity was $0, compared with $0 a year earlier.
Context
- Other stockholders equity amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Other stockholders equity increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Stockholders Equity history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Stockholders Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Stockholders Equity vs competitors
How HCA compares with its peers on the latest reported figures
- HCA's Jun 2026 other stockholders equity of $0 is the 2nd highest of the 6 companies compared; the peer median is $0.
- Other stockholders equity amounts to 0.0% of total assets for HCA, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ARDTArdent Health Partners, LLC | Mar 2026 | $1.19B | — | — | 22.7% |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | -$789.82M | -6.7% | — | 5.0% | |
| Peer median (excluding HCA) | $0 | -6.7% | — | 0.0% | |
Competitors are the stored peer set for HCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.45B | 908M | 935M | 1.93B | 1.04B |
| Short-term Investments | 0 | 0 | 0 | 88M | 0 |
| Net Receivables | 8.1B | 8.89B | 9.96B | 10.75B | 10.87B |
| Inventory | 1.99B | 2.07B | 2.02B | 1.74B | 1.65B |
| Other Current Assets | 2.01B | 1.78B | 2.01B | 1.9B | 0 |
| Total Current Assets | 13.54B | 13.64B | 14.93B | 16.41B | 13.56B |
| Property, Plant & Equipment (Net) | 26.18B | 27.64B | 29.92B | 31.55B | 31.14B |
| Goodwill | 9.14B | 9.29B | 9.61B | 9.77B | 0 |
| Intangible Assets | 403M | 359M | 339M | 323M | 10.29B |
| Long-term Investments | 886M | 1.2B | 1.23B | 1.23B | 633M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 598M | 298M | 184M | 230M | 5.09B |
| Total Non-current Assets | 37.2B | 38.8B | 41.28B | 43.1B | 47.16B |
| Total Assets | 50.74B | 52.44B | 56.21B | 59.51B | 60.72B |
| Account Payables | 4.11B | 4.24B | 4.23B | 4.28B | 4.66B |
| Short-term Debt | 237M | 370M | 2.42B | 4.7B | 6.74B |
| Tax Payables | 361M | 371M | 382M | 419M | 2.22B |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 549M | 794M | 867M | 910M | 2.42B |
| Total Current Liabilities | 9.58B | 9.9B | 12.66B | 15.18B | 16.35B |
| Long-term Debt | 33.77B | 37.14B | 37.17B | 38.33B | 41.6B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3.57B | 3.14B | 3.42B | 3.59B | 3.69B |
| Total Non-current Liabilities | 39.67B | 42.61B | 42.5B | 43.78B | 47.14B |
| Total Liabilities | 49.25B | 52.51B | 55.15B | 58.96B | 63.49B |
| Common Stock | 3M | 3M | 3M | 3M | 2M |
| Retained Earnings | (532M) | (2.28B) | (1.35B) | (2.12B) | (5.72B) |
| Accumulated OCI | (404M) | (490M) | (425M) | (387M) | (305M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 2.42B | 2.69B | 2.83B | 3.05B | 3.26B |
| Total Equity | 1.49B | (73M) | 1.06B | 555M | (2.77B) |
| Total Debt | 36.73B | 40.2B | 41.86B | 45.24B | 50.2B |
| Net Debt | 35.28B | 39.29B | 40.92B | 43.3B | 49.16B |
HCA Healthcare, Inc.
NYSE:HCA
Intrinsic Alpha fair value
Locked
Current Price
$476.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.